CompletedNCT00001483
Antidepressant options for depression
About this title
Acute Effectiveness of Additional Drugs to the Standard Treatment of Depression
Read the official source — NCT00001483Medication studyUnited States
Understand this study
Who was this study for?
This study was for people with bipolarity. Other eligibility criteria applied.
- Listed locations
- BethesdaSee all locations and recruitment
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Study information
Study start dateJune 1995
- Recruitment status
- Completed
- Enrollment listed in the registry
- 75
- Sponsor
- National Institute of Mental Health (NIMH)
- Sponsor type
- Government agency
- Study type
- Drug
- Intervention type
- Medication / drug
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
- Locations
- United States
- Age range
- Not clearly listed
- Official registry ID
- NCT00001483
- Official title
Show the full official title
Acute Efficacy of Bupropion, Sertraline, and Venlafaxine as Adjuvant Treatment to Mood Stabilizers in Bipolar Depression: A Randomized, Double-Blind, Comparative Study
Get this study by email
Recruitment & locations
CompletedBethesda
Questions about this study
Who is behind this study?
The study sponsor is National Institute of Mental Health (NIMH), a government agency.
Did this study involve medication?
Yes. The study involved medication, including buproprion (Wellbutrin), sertraline (Zoloft) and venlafaxine (Effexor).
Who was this study for?
This study was for people with bipolarity. Other eligibility criteria applied.
